The judgment of the lawsuit that challenges the constitutionality of the sole paragraph of Article 40 of the Brazilian Patent Law (ADI no. 5,529) scheduled for April 07, 2021 was removed from the Supreme Court agenda in view of the urgent need to analyze a pandemic-related court action. However, the Reporting-Minister granted a preliminary injunction that suspends this legal provision only for patents related to pharmaceutical products and processes until the trial occurs. Article 40 establishes...